NOT-HL-20-817: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-001 "Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)"

NOT-HL-20-817: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-001 "Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)"

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

            

General Notices

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-001 "Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)"
(NOT-HL-20-817)
National Heart, Lung, and Blood Institute

Review of the Accuracy of Grants Information for Fiscal Year 2020
(NOT-OD-20-175)
National Institutes of Health

 

Notice of Changes to Funding Opportunities

Notice of Change to NIEHS target FOAs for NOT-HL-20-788 "Notice of Special Interest (NOSI): Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations"
(NOT-HL-20-015)
National Heart, Lung, and Blood Institute
National Institute of Environmental Health Sciences

Notice of NHLBI Participation in RFA-OD-19-029: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
(NOT-HL-20-812)
National Heart, Lung, and Blood Institute